Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
STOK
STOK News & Events
-
Add to Watchlist
Trade STOK
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
STOK Stock News Today | Earnings, Events & Price Alerts
STOK News
Stoke Therapeutics Launches ADOA Treatment Study with STK-002
Feb 11 2026
Newsfilter
Analysis of Stoke Therapeutics Options Trading
Jan 30 2026
NASDAQ.COM
Stoke Therapeutics Secures New Headquarters in Waltham
Jan 27 2026
PRnewswire
Stoke Therapeutics Secures New Headquarters in Waltham for Growth and Research Expansion
Jan 27 2026
Newsfilter
Exelixis Reports Preliminary 2025 Revenue of $2.123 Billion, Shares Drop 4.6%
Jan 12 2026
Benzinga
Bark Inc (BARK) Shares Surge 19.9% on Acquisition Proposal from Great Dane
Jan 12 2026
Benzinga
Stoke Therapeutics Accelerates EMPEROR Study Timeline, Expects Patient Enrollment by Q2 2026
Jan 12 2026
NASDAQ.COM
Stoke Accelerates Dravet Syndrome Drug Development, Expects 150 Patient Enrollment by 2026
Jan 11 2026
Businesswire
Show More News
STOK Events
02/11 07:40
Stoke Therapeutics Doses First Patient in STK-002 Trial
Stoke Therapeutics announced that the first patient has been dosed in the Phase 1 OSPREY study of STK-002, an investigational medicine for the treatment of Autosomal Dominant Optic Atrophy.
Show More Events
STOK Monitor News
No data
STOK Earnings Analysis
No Data
People Also Watch
